- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Fortis Healthcare net profit falls 69 percent at Rs 134 crore in Q1
The company continues to further strengthen the business in terms of adding beds, expanding medical programmes, and onboarding clinical talent, he added.
New Delhi: Fortis Healthcare has reported 69 percent decline in consolidated net profit at Rs 134 crore for the first quarter ended June 30.
The healthcare major had logged a net profit of Rs 431 crore, which included an exceptional gain of Rs 306 crore, in April-June 2021-22.
Revenues in the period under review stood at Rs 1,488 crore as compared with Rs 1,410 crore in the year-ago period, the company said in a late evening regulatory filing on Friday.
"With COVID abating, our hospital business has shown a strong uptrend relative to the diagnostics business which has seen a decline in volumes due to a higher COVID-led base in both Q1 and Q4 of FY22," Fortis Healthcare Chairman Ravi Rajagopal said.
The company continues to further strengthen the business in terms of adding beds, expanding medical programmes, and onboarding clinical talent, he added.
Read also: Sun Pharma net profit up 43 percent at Rs 2,061 crore in Q1
"Our next phase of growth would be led by our brownfield expansion strategy which would see around 1,500 beds coming onstream in the next few years, largely in key existing Fortis facilities such as the likes of FMRI, Mohali, Shalimar Bagh, BG Road and Noida," Rajagopal said.
This coupled with focus on digital initiatives in both the medical and non-medical related aspects should enable the healthcare firm to further fortify its longer-term business prospects, he added.
Read also: Fortis Hospital Bengaluru introduces De-addiction Programme
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751